Hoel Sette

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Francesca J. Torriani, M. Rodríguez‐Torres, Jürgen K. Rockstroh et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

Entecavir therapy for lamivudine‐refractory chronic hepatitis B

Morris Sherman, Cihan Yurdaydın, Halis Şimşek et al. · Hepatology · 2008 · 168 citations · Full text

Estimated Prevalence of Viral Hepatitis in the General Population of the Municipality of São Paulo, Measured by a Serologic Survey of a Stratified, Randomized and Residence-Based Population.

Roberto Focaccia, da Conceição Oj, Hoel Sette et al. · PubMed · 1998 · 153 citations

Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis

Eugene R. Schiff, Halis Şimşek, William M. Lee et al. · The American Journal of Gastroenterology · 2008 · 137 citations

Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose

S. Hadziyannis, Hugo Cheinquer, Timothy M. Morgan et al. · Journal of Hepatology · 2002 · 133 citations

Medicine, Phase Iii, Clinical Trials +9